Humacyte Inc (NASDAQ:HUMA) shares are trading lower by 29.2% to $3.08 during Friday’s session after the company announced pricing of a $40.2 million public offering of common stock.
Humacyte priced its underwritten public offering of 13.4 million shares of common stock at $3.00 per share. The offering is expected to close on March 5, pending customary closing conditions. Additionally, the underwriters have an option to purchase up to an additional 2.01 million shares within 30 days.
The proceeds will be ...
HUMA) Shares Are Falling>Full story available on Benzinga.com